BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Prognosis
38 results:

  • 1. STIM1/sox2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinoma.
    Sweed D; Elhamed SMA; Aiad HAS; Ehsan NA; Hemida AS; Dawoud MM
    World J Surg Oncol; 2024 Mar; 22(1):84. PubMed ID: 38532463
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer.
    Wu J; Tan HY; Chan YT; Lu Y; Feng Z; Yuan H; Zhang C; Feng Y; Wang N
    J Exp Clin Cancer Res; 2024 Feb; 43(1):42. PubMed ID: 38317186
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. GCF2 mediates nicotine-induced cancer stemness and progression in hepatocellular carcinoma.
    Li J; Tuo D; Cheng T; Deng Z; Gan J
    Ecotoxicol Environ Saf; 2024 Feb; 271():115952. PubMed ID: 38218109
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death.
    Huang TY; Yang CK; Chen MY; Yadav VK; Fong IH; Yeh CT; Cherng YG
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299411
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation.
    Liu X; Ye Y; Zhu L; Xiao X; Zhou B; Gu Y; Si H; Liang H; Liu M; Li J; Jiang Q; Li J; Yu S; Ma R; Su S; Liao JY; Zhao Q
    Nat Commun; 2023 Jan; 14(1):238. PubMed ID: 36646707
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
    Liu B; Fang X; Kwong DL; Zhang Y; Verhoeft K; Gong L; Zhang B; Chen J; Yu Q; Luo J; Tang Y; Huang T; Ling F; Fu L; Yan Q; Guan XY
    J Exp Clin Cancer Res; 2022 May; 41(1):182. PubMed ID: 35610614
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict prognosis in Hepatocellular Carcinoma.
    Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
    Dis Markers; 2022; 2022():2676114. PubMed ID: 35465267
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. miR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer.
    Li Y; Xun J; Wang B; Ma Y; Zhang L; Yang L; Gao R; Guan J; Liu T; Gao H; Wang X; Zhang Q
    J Transl Med; 2021 Oct; 19(1):429. PubMed ID: 34656128
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
    Correnti M; Cappon A; Pastore M; Piombanti B; Lori G; Oliveira DVPN; Munoz-Garrido P; Lewinska M; Andersen JB; Coulouarn C; Sulpice L; Peraldo Neia C; Cavalloni G; Quarta S; Biasiolo A; Fassan M; Ramazzotti M; Parri M; Recalcati S; di Tommaso L; Campani C; Invernizzi P; Torzilli G; Marra F; Pontisso P; Raggi C
    Liver Int; 2022 Jan; 42(1):233-248. PubMed ID: 34478594
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. sox2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression.
    Hosseini-Khah Z; Babaei MR; Tehrani M; Cucchiarini M; Madry H; Ajami A; Rakhshani N; Rafiei A; Nikbin B
    Curr Oncol; 2021 Aug; 28(4):3015-3029. PubMed ID: 34436030
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.
    Bian X; Shi D; Xing K; Zhou H; Lu L; Yu D; Wu W
    Clin Transl Med; 2021 Mar; 11(3):e352. PubMed ID: 33783988
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells.
    Wang J; Zhao H; Zheng L; Zhou Y; Wu L; Xu Y; Zhang X; Yan G; Sheng H; Xin R; Jiang L; Lei J; Zhang J; Chen Y; Peng J; Chen Q; Yang S; Yu K; Li D; Xie Q; Li Y
    Theranostics; 2021; 11(10):5045-5060. PubMed ID: 33754043
    [No Abstract]    [Full Text] [Related]  

  • 13. Loss of miR-100 and miR-125b results in cancer stem cell properties through IGF2 upregulation in hepatocellular carcinoma.
    Seol HS; Akiyama Y; Lee SE; Shimada S; Jang SJ
    Sci Rep; 2020 Dec; 10(1):21412. PubMed ID: 33293585
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-sox2 signaling.
    Lu J; Bang H; Kim SM; Cho SJ; Ashktorab H; Smoot DT; Zheng CH; Ryeom SW; Yoon SS; Yoon C; Lee JH
    Oncogene; 2021 Feb; 40(5):922-936. PubMed ID: 33288885
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Clinical and Prognostic Implications of Pluripotent Stem Cell Markers Expression and Their Correlation with the WNT signal pathway in Hepatocellular Carcinoma.
    Osman NAA; Khalil AI; Yousef RK
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2961-2970. PubMed ID: 33112555
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tonicity-responsive enhancer-binding protein promotes stemness of liver cancer and cisplatin resistance.
    Lee JH; Suh JH; Kang HJ; Choi SY; Jung SW; Lee-Kwon W; Park SA; Kim H; Ye BJ; Yoo EJ; Jeong GW; Park NH; Kwon HM
    EBioMedicine; 2020 Aug; 58():102926. PubMed ID: 32739873
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact.
    Tsunedomi R; Yoshimura K; Suzuki N; Hazama S; Nagano H
    Surg Today; 2020 Dec; 50(12):1560-1577. PubMed ID: 32025858
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Role of cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
    Wu HJ; Chu PY
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Six1 is negatively correlated with poor prognosis and reduces 5-fluorouracil sensitivity via attenuating the stemness of hepatocellular carcinoma cells.
    Chen K; Wei H; Pan J; Chen Z; Pan D; Gao T; Huang J; Huang M; Ou M; Zhong W
    Eur J Pharmacol; 2019 Oct; 861():172599. PubMed ID: 31404537
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 2.